Cyclobenzaprine Overdosage
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 20 (3) , 281-288
- https://doi.org/10.3109/15563658308990071
Abstract
The clinical findings in three patients who ingested 260-900 mg cyclobenzaprine (FlexerilW) consisted of delayed onset and long duration of anticholinergic symptomatology. In two of these patients, symptoms responded to treatment with physostigmine. The third patient recovered without specific therapy. Despite its structural similarity to amitriptyline, cyclobenzaprine overdosage did not result in coma, seizures, or cardiac toxicity. The pharmacological properties of cyclobenzaprine may account for the observed toxicity.This publication has 14 references indexed in Scilit:
- Cyclobenzaprine: A new type of anti-parkinsonian drugProgress in Neuro-Psychopharmacology, 1978
- Cyclobenzaprine: Some pharmacological cardiac actionsLife Sciences, 1978
- Plasma Levels and Bioavailability of Cyclobenzaprine in Human SubjectsThe Journal of Clinical Pharmacology, 1977
- Tricyclic Antidepressant OverdoseJAMA, 1977
- Cyclobenzaprine: A novel centrally acting skeletal muscle relaxantNeuropharmacology, 1975
- Physostigmine Salicylate in the Treatment of Tricyclic Antidepressant OverdosagePublished by American Medical Association (AMA) ,1975
- Assessment of cyclobenzaprine in the treatment of spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1972
- Correlation between the experimental data from animal studies and therapeutical effects of antidepressant drugsPsychopharmacology, 1971
- The Reversal of Anticholinergic Drug-Induced Delirium and Coma with PhysostigmineAmerican Journal of Psychiatry, 1971
- A new agent for the control of spasticityJournal of Neurology, Neurosurgery & Psychiatry, 1970